0001209191-14-059468.txt : 20140923
0001209191-14-059468.hdr.sgml : 20140923
20140923193247
ACCESSION NUMBER: 0001209191-14-059468
CONFORMED SUBMISSION TYPE: 5
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20100331
FILED AS OF DATE: 20140923
DATE AS OF CHANGE: 20140923
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KYTO BIOPHARMA INC
CENTRAL INDEX KEY: 0001164888
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 651086538
STATE OF INCORPORATION: FL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 41A AVENUE ROAD AT YORK SQUARE
CITY: TORONTO ONTARIO
STATE: A1
ZIP: 00000
BUSINESS PHONE: 416-955-0159
FORMER COMPANY:
FORMER CONFORMED NAME: B TWELVE INC
DATE OF NAME CHANGE: 20020111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MEDAREX INC
CENTRAL INDEX KEY: 0000874255
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 5
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50390
FILM NUMBER: 141117006
BUSINESS ADDRESS:
STREET 1: 707 STATE ROAD 206
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 9087136001
MAIL ADDRESS:
STREET 1: 707 STATE ROAD 206
CITY: PRINCETON
STATE: NJ
ZIP: 08540
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO
CENTRAL INDEX KEY: 0000014272
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 5
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50390
FILM NUMBER: 141117007
BUSINESS ADDRESS:
STREET 1: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10154
BUSINESS PHONE: 2125464000
MAIL ADDRESS:
STREET 1: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10154
FORMER NAME:
FORMER CONFORMED NAME: BRISTOL MYERS CO
DATE OF NAME CHANGE: 19891012
5
1
doc5.xml
FORM 5 SUBMISSION
X0306
5
2010-03-31
0
1
0
0001164888
KYTO BIOPHARMA INC
KBPH
0000014272
BRISTOL MYERS SQUIBB CO
345 PARK AVENUE
NEW YORK
NY
10154
0
0
1
0
0000874255
MEDAREX INC
C/O BRISTOL-MYERS SQUIBB COMPANY
345 PARK AVENUE
NEW YORK
NY
10154
0
0
1
0
Common Stock
3
1300000
I
By Medarex, L.L.C.
Bristol-Myers Squibb Company ("BMS") recently identified its indirect ownership of 1,300,000 shares of common stock of Kyto Biopharma, Inc. ("Kyto"). These shares are owned directly by Medarex, L.L.C. (formerly known as Medarex, Inc.) ("Medarex"), a wholly-owned subsidiary of BMS. BMS acquired Medarex on September 1, 2009. At that time, Medarex owned 1,300,000 Kyto shares but only provided BMS with a stock certificate, in the name of Kyto's predecessor company B. Twelve, Inc., for 400,000 shares.
Bristol-Myers Squibb Company, By: /s/ Katherine R. Kelly, Vice President & Assistant Secretary
2014-09-23
Medarex, L.L.C. (formerly known as Medarex, Inc.), By: /s/ Katherine R. Kelly, Secretary
2014-09-23